Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may downregulate T2R43 by inhibiting histone deacetylases, leading to tighter chromatin packing and reduced transcriptional activity at the T2R43 gene locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could decrease T2R43 expression through DNA demethylation, which may silence gene transcription by altering the epigenetic status of the T2R43 promoter region. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By specifically inhibiting histone deacetylase, Trichostatin A may downregulate T2R43 by changing the acetylation state of histones associated with the gene, affecting its expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may decrease T2R43 expression by binding to retinoic acid receptors that heterodimerize with retinoid X receptors, which then bind to retinoic acid response elements in the gene's promoter. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could inhibit T2R43 expression by blocking mTOR signaling which is crucial for protein synthesis and cell growth, leading to a reduction in overall protein expression levels. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may reduce T2R43 expression by elevating intracellular cAMP, which activates protein kinase A and leads to changes in the phosphorylation of transcription factors that govern T2R43 gene transcription. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
As a Wnt/β-catenin pathway inhibitor, XAV939 could downregulate T2R43 by preventing β-catenin from translocating to the nucleus and activating T-cell factor/lymphoid enhancer factor transcription of the gene. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may inhibit T2R43 by blocking PI3K, which is instrumental in the Akt signaling pathway that can promote transcriptional activity of various genes, including potentially T2R43. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may reduce T2R43 expression by inhibiting MEK, which is part of the MAPK/ERK pathway that regulates gene expression by controlling the activity of transcription factors. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
This NF-κB inhibitor could decrease T2R43 expression by preventing NF-κB from binding to DNA and initiating transcription of target genes, which may include T2R43. | ||||||